By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets and based on stabilized helical peptides or Helicons, has filed for an IPO.

Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new screening system for targeting receptors long ...

By mapping how genes relate to one another across biological situations, GSFM creates a reference framework that can help ...

Roughly 2700 attendees heard a range of perspectives from experts in precision medicine, bioinformatics, and rare disease ...

One of CRS’ first customers is SRTD Biotech, an emerging biotech in Germany, which is starting small scale on novel ...

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.

Biotech companies that use CDD Vault will be able to utilize select Lilly predictive models within their natural scientific ...

Wisconsin Governor Tony Evers (center) leads the ribbon-cutting ceremony at FUJIFILM Cellular Dynamics’ new headquarters and manufacturing facility in Madison, WI. [FUJIFILM Cellular Dynamics] In ...

AI scientists propose to automate the scientific method and accelerate drug discovery, where traditional timelines can span a ...

Regeneron Pharmaceuticals will partner with Parabilis Medicines to discover and develop an initial five candidates ...